DARA BioSciences, Inc. (DARA)
DARA BioSciences, Inc. is a Raleigh, North Carolina based development-stage Biopharmaceutical Company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies.
Diabetes mellitus is one of the leading causes of irreversible blindness worldwide, and, in the United States, it is the most common cause of blindness in people younger than 65 years of age. In addition to being a leading cause of blindness, diabetic eye disease encompasses a wide range of problems that can affect the eyes.
Diabetes mellitus may cause a reversible, temporary blurring of the vision, or it can cause a severe, permanent loss of vision.
Diabetes mellitus increases the risk of developing cataracts and glaucoma.
The company continues to build a diverse pipeline, including candidates for the treatment of metabolic diseases (diabetes), and pain.
DARA BioSciences, Inc.’s shares are publicly traded on the NASDAQ under the ticker symbol DARA.
DARA BioSciences, Inc. reported that SurgiVision, Inc., a privately held company, and Brainlab AG, announced on April 11 collaboration aimed at integrating SurgiVision’s ClearPoint(R) product line with Brainlab’s iMRI product line, with particular focus on local delivery of drugs and other therapeutic agents to precision targets in the brain under magnetic resonance imaging (MRI) guidance. DARA presently owns over 500,000 shares and warrants of SurgiVision.
For more information about DARA please visit http://www.darabiosciences.com
General Growth Properties Inc. (NYSE:GGP) announced the refinancing of seven shopping malls representing $1.7 billion of new mortgages ($1.4 billion is GGP’s share). These seven new fixed-rate mortgages have a weighted average term of 10.3 years and generated cash proceeds in excess of in-place financing of approximately $400 million to GGP. GGP has also been able to lower the weighted average interest rate of these seven mortgages from 5.65% to 5.33%, while lengthening the term by approximately seven years over that in place.
General Growth Properties, Inc. operates as a real estate investment trust in the United States. It operates in two segments, Retail and Other, and Master Planned Communities.
Kinross Gold Corporation (NYSE:KGC) announced that its 75%-owned subsidiary, Chukotka Mining and Geological Company (”CMGC”), has entered into a Share Purchase Agreement with the State Unitary Enterprise of the Chukotka Autonomous Okrug or “CUE”, to repurchase the 2,292,348 shares of CMGC currently held by CUE, representing 25.01% of CMGC’s outstanding share capital, for an approximate consideration of US$350 million, subject to adjustments equal to the amount of the attributable dividend payments. On completion of the transaction, Kinross will own 100% of CMGC, which in turn, holds both the Kupol mine and the Kupol East-West exploration licences in the Chukotka region of the Russian Federation.
Kinross Gold Corporation, together with its subsidiaries, engages in mining and processing gold ores. It also involves in the exploration and acquisition of gold bearing properties.
Charles Schwab Corp. (NYSE:SCHW) announced that it has scheduled an Interim Business Update for institutional investors on Wednesday, April 20, 2011. This Update, which will be held via webcast, is part of an ongoing series designed to help the investment community keep abreast of recent developments and management’s strategic focus. The program is scheduled to run from 8:00 a.m. - 9:00 a.m. PT, 11:00 a.m. - 12:00 p.m. ET. Participants will include Walt Bettinger, President & Chief Executive Officer, and Joe Martinetto, Chief Financial Officer.
The Charles Schwab Corporation, through its subsidiaries, provides securities brokerage, banking, and related financial services to individuals and institutional clients.
No comments:
Post a Comment